Genetic and epigenetic changes to the glucocorticoid receptor gene (NR3C1) and cognition in major depressive disorder.


Por: Ferrer A, Labad J, Salvat-Pujol N, Urretavizcaya M, Obrador-Font R, Menchón JM, Palao D, Soriano-Mas C, Costas J, Barrachina M, Carracedo Á and Soria V

Ahead of Print: 4 abr 2025
Resumen:
INTRODUCTION: Many studies have found that hypothalamic-pituitary-adrenal (HPA) axis abnormalities are related to the pathophysiology of major depressive disorder (MDD) and cognitive functioning. Our aim was to assess the influence of genetic polymorphisms and methylation levels in three different promoter regions throughout the glucocorticoid receptor (GR) gene NR3C1 on cognitive performance in MDD. Plausible interactions with childhood adversity and mediation relationships between genetic and epigenetic variables were explored. MATERIALS AND METHODS: The sample included a total of 64 MDD patients and 82 healthy controls. Child maltreatment and neurocognitive performance were assessed in all participants. HPA negative feedback was analyzed using the dexamethasone suppression test after the administration of 0.25mg of dexamethasone. A total of 23 single-nucleotide polymorphisms were genotyped, and methylation levels at several CpGs in exons 1D, 1F and 1H of the GR gene were measured. RESULTS: Results show that, beyond the influence of other covariables, NR3C1 single-nucleotide polymorphisms and methylation levels predicted performance in executive functioning and working memory tasks. No significant interactions or mediation relationships were detected. CONCLUSIONS: Results suggest that genetic variations and epigenetic regulation of the GR gene are relevant factors influencing cognitive performance in MDD and could emerge as significant biomarkers and therapeutic targets in mood disorders and other stress-related disorders.

Filiaciones:
Ferrer A:
 Department of Mental Health, Parc Taulí Hospital Universitari, Sabadell, Catalonia, Spain

 Institut de Investigació i Innovació Parc Taulí (I3PT), Sabadell, Catalonia, Spain

 Escoles Universitàries Gimbernat, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

:
 Institut de Investigació i Innovació Parc Taulí (I3PT), Sabadell, Catalonia, Spain

 Department of Mental Health, Consorci Sanitari del Maresme, Mataró, Catalonia, Spain

 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

Salvat-Pujol N:
 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Neurosciences Group - Psychiatry and Mental Health, Barcelona, Catalonia, Spain

 Hospital Universitari Institut Pere Mata, IISPV, Universitat Rovira i Virgili, Reus, Catalonia, Spain

Urretavizcaya M:
 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Neurosciences Group - Psychiatry and Mental Health, Barcelona, Catalonia, Spain

 Department of Clinical Sciences, Universitat de Barcelona, Barcelona, Catalonia, Spain

Obrador-Font R:
 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Neurosciences Group - Psychiatry and Mental Health, Barcelona, Catalonia, Spain

Menchón JM:
 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Neurosciences Group - Psychiatry and Mental Health, Barcelona, Catalonia, Spain

 Department of Clinical Sciences, Universitat de Barcelona, Barcelona, Catalonia, Spain

Palao D:
 Department of Mental Health, Parc Taulí Hospital Universitari, Sabadell, Catalonia, Spain

 Institut de Investigació i Innovació Parc Taulí (I3PT), Sabadell, Catalonia, Spain

 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

 Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Catalonia, Spain

Soriano-Mas C:
 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Neurosciences Group - Psychiatry and Mental Health, Barcelona, Catalonia, Spain

 Department of Social and Quantitative Psychology, Universitat de Barcelona, Catalonia, Spain

Costas J:
 Instituto de Investigación Sanitaria (IDIS) de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Galicia, A Coruña, Spain

Barrachina M:
 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Neurosciences Group - Psychiatry and Mental Health, Barcelona, Catalonia, Spain

 Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain

Carracedo Á:
 Grupo de Medicina Xenómica, Universidade de Santiago de Compostela, Centro Nacional de Genotipado - Instituto Carlos III, Santiago de Compostela, A Coruña, Spain

 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain

Soria V:
 Department of Mental Health, Parc Taulí Hospital Universitari, Sabadell, Catalonia, Spain

 Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

 Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Neurosciences Group - Psychiatry and Mental Health, Barcelona, Catalonia, Spain

 Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Catalonia, Spain
ISSN: 29502861





Spanish Journal of Psychiatry and Mental Health
Editorial
ELSEVIER ESPANA SLU, Carrer de Tarragona, 161 15th floor, BARCELONA, SPAIN, España
Tipo de documento: Article
Volumen: Número:
Páginas:
ID de PubMed: 40189105

MÉTRICAS